Related Experiment Videos
Percutaneous revascularization strategies. Usefulness in ischemic coronary artery disease
1Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Insights
Revascularization procedures, including angioplasty and bypass surgery, are beneficial for patients with ischemic symptoms or silent myocardial ischemia. New devices like coronary stents expand treatment options in cardiac laboratories.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Revascularization procedures are indicated for patients experiencing ischemic symptoms or silent myocardial ischemia.
- Extensive coronary artery disease may warrant intervention even without demonstrable ischemia.
- Advancements in devices, such as coronary stents, have expanded the scope of cardiac laboratory interventions.
Purpose of the Study:
- To review current data supporting revascularization procedures for ischemic heart disease.
- To discuss the role of new devices in expanding treatment options.
- To outline treatment strategies for acute myocardial infarction and stable angina.
Main Methods:
- Review of current clinical data and treatment guidelines.
- Discussion of the impact of new interventional cardiology devices.
- Analysis of treatment algorithms for different ischemic heart disease presentations.
Main Results:
- Revascularization is supported for ischemic symptoms and silent myocardial ischemia.
- Coronary stents have broadened patient eligibility for cardiac laboratory procedures.
- Direct angioplasty is preferred for acute myocardial infarction; rescue angioplasty is considered for failed thrombolysis.
- Both bypass surgery and angioplasty are viable initial strategies for stable angina or significant silent ischemia.
Conclusions:
- Revascularization procedures are valuable for a wide range of patients with ischemic heart disease.
- Interventional cardiology advancements continue to improve treatment accessibility and outcomes.
- Tailored revascularization strategies are essential for optimal patient management in both acute and chronic settings.
Abstract:
Current data support the use of revascularization procedures in many patients with ischemic symptoms or silent myocardial ischemia. Patients with extensive disease may benefit even when ischemia cannot be demonstrated. The development of new devices, particularly coronary stents, has broadened the population of patients who can be treated in the cardiac laboratory. Patients with acute myocardial infarction are best treated with direct angioplasty. If thrombolytic therapy is used, rescue angioplasty should probably be done when lysis is unsuccessful. Angioplasty should be used selectively in patients with successful thrombolysis. Both bypass surgery and angioplasty are reasonable initial strategies for patients with stable angina or significant silent ischemia who require coronary revascularization.